e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Exercise in respiratory diseases and oxygen therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The major limitation to exercise tolerance in COPD patients at Bogota (2640m) is hypoxemia
M. Gonzalez-Garcia, M. Barrero, D. Maldonado (Bogota, Colombia)
Source:
Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Session:
Exercise in respiratory diseases and oxygen therapy
Session type:
Thematic Poster Session
Number:
4390
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gonzalez-Garcia, M. Barrero, D. Maldonado (Bogota, Colombia). The major limitation to exercise tolerance in COPD patients at Bogota (2640m) is hypoxemia. Eur Respir J 2010; 36: Suppl. 54, 4390
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015
Reduced submaximal exercise performance in COPD patients at moderate altitude (2590m)
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014
Exercise endurance in hypoxemic COPD patients at an altitude of 2460m breathing air and oxygen (FIO2 28% and 35%)
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010
Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016
Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Postural control in COPD patients travelling from 760 m to 3200 m; randomized trial evaluating effects of dexamethasone
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Cerebral oxygenation in lowlanders with COPD spending a night at 2590m
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Time to desaturation under 1 minute on the 6m walking test predicts chronic domiciliary oxygen therapy in COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Altitude related adverse health effects in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Breathing and sleep disturbances in lowlanders with COPD travelling to 2590m
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Differences between walking and stair climbing in severe COPD patients receiving and not receiving long-term NIV
Source: Annual Congress 2007 - Physiological effects of noninvasive ventilation
Year: 2007
Negative pressure ventilation decreases lung function decline, acute exacerbations and hospitalizations in COPD patients with desaturation during 6 minute walk test
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Maximal respiratory pressures and exercise tolerance in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 109s
Year: 2005
Effect of dopamine infusion and oxygen supplementation on exercise ventilatory response and endurance in COPD
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Exercise tolerance with helium-hyperoxia versus hyperoxia in hypoxaemic patients with COPD
Source: Eur Respir J 2013; 42: 362-370
Year: 2013
COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept